MATISSE PHARMACEUTICALS
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock.
MATISSE PHARMACEUTICALS
Industry:
Biopharma Biotechnology Life Science
Founded:
2014-01-01
Address:
Geleen, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.matisse-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0)88 2554 070
Email Addresses:
[email protected]
Total Funding:
1.9 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro Pound Sterling Japanese Yen Wix
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Axichem
Axichem is an biotechnology company specializing in development of natural analogue ingredients.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Materiomics BV
Materiomics BV is a biotech company located in Enschede, The Netherlands.
Current Advisors List
Current Employees Featured
Investors List
Chemelot Ventures
Chemelot Ventures investment in Venture Round - Matisse Pharmaceuticals
Limburg Business Development Fund (LBDF)
Limburg Business Development Fund (LBDF) investment in Venture Round - Matisse Pharmaceuticals
Official Site Inspections
http://www.matisse-pharma.com
- Host name: webhosting.transip.nl
- IP address: 86.105.244.1
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
